BetterLife Pharma Inc. files as a foreign private issuer, and its SEC reports document current-event disclosures furnished on Form 6-K. The filings include news releases, material change reports, management’s discussion and analysis, financial statements, and CEO and CFO certifications.
BetterLife’s filings cover its biopharmaceutical development focus around BETR-001, financial reporting, liquidity and capital actions, governance updates, and public disclosure matters tied to its Canadian reporting framework and U.S. OTC-quoted security.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.60%
Tags
FAQ
How many BetterLife Pharma (BETRF) SEC filings are available on StockTitan?
StockTitan tracks 11 SEC filings for BetterLife Pharma (BETRF), including 20-F annual reports and 6-K reports. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for BetterLife Pharma (BETRF)?
The most recent SEC filing for BetterLife Pharma (BETRF) was filed on September 29, 2025.